BioNxt Solutions (CSE: BNXT) Consolidates R&D at Gen-Plus Lab in Munich
BioNxt Solutions Inc. (CSE: BNXT; OTC PINK: BNXTF; FSE: BXT) has announced the consolidation of its research, development, and commercialization activities into the 1,000-square-meter Gen-Plus GmbH & Co. KG Contract Research and Development Organization (CRDO) in Munich, Germany. The move marks a strategic operational …
Team Kalkine |
13 May 2025| Read Time : 10 Mins